MDMA in adolescent male rats: Decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 643-649

  Faria, Raquel ^a   Magalhães, Ana ^a   Monteiro, Pedro R R ^a,b   Gomes Da Silva, Joana ^a,c   Tavares, Maria Amélia ^a,d   Summavielle, Teresa ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c UNIVERSITY OF AVEIRO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Amygdala; Anxiety; Dopamine; Ecstasy; MDMA; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APPARATUS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; ELEVATED PLUS MAZE TEST; GROOMING; HEAD MOVEMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAZE TEST; METABOLITE; NEUROTOXICITY; NONHUMAN; RAT; REARING; SEROTONIN BRAIN LEVEL;

ANIMALIA;

EID: 33749555776     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.062     Document Type: Conference Paper

References (23)

1. LYLES, J. & J.L. CADET. 2003. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res. Brain Res. Rev. 42: 155-168.
2. MINTZ, M. & Y. WANG-NINIO. 2001. Two-stage theory of conditioning: involvement of the cerebellum and the amygdala. Brain Res. 897: 150-156.
3. LEDOUX, J. 2000. The amygdala and emotion a view through fear. In The Amygdala. J.P. Aggleton, Ed.: 289-310. Oxford University Press. Oxford.
4. ANTONIADIS, E.A. & R.J. MCDONALD. 2001. Amygdala, hippocampus, and unconditioned fear. Exp. Brain Res. 138: 200-209.
5. PACKARD, M.G., L. CAHILL & J.L. MCGAUGH. 1994. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc. Natl. Acad. Sci. USA. 91: 8477-8481.
6. EVERITT, B.J., R.N. CARDINAL, J. HALL, et al. 2000. Differential involvement of amygdala subsystems in appetitive conditioning and drug addiction. In The Amygdala. J.P. Aggleton, Ed. 353-390. Oxford University Press. Oxford.
7. GREBA, Q., A. GIFKINS & L. KOKKINIDIS. 2001. Inhibition of amygdaloid dopamine D(2) receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 899:218-226.
8. SUMNALL, H.R. et al. 2004. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test. Pharmacol. Biochem. Behav. 77: 805-814.
9. ALI, S.F., S.N. DAVID & G.D. NEWPORT. 1993. Age-related susceptibility of MPTP-induced neurotoxicity in mice. Neurotoxicology 14: 29-34.
10. BRADFORD, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 72: 248-254.
11. BANKSON, M.G. & K.A. CUNNINGHAM. 2001. 3,4- Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J. Pharmacol. Exp. Ther. 297: 846-852.
12. MCCREARY, A.C., M.G. BANKSON & K.A. CUNNINGHAM. 1999. Pharmacological studies of the acute and chronic effects of (+)-3,4- methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J. Pharmacol. Exp. Ther. 290: 965-973.
13. BRODERICK, P.A. & C.F. PHELIX. 1997. I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior. Neurosci. Biobehav. Rev. 21: 227-260.
14. GURTMAN, C.G. et al. 2002. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur. J. Pharmacol. 446: 89-96.
15. COLADO, M.I., J.L. WILLIAMS & A.R. GREEN. 1995. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br. J. Pharmacol. 115: 1281-1289.
16. O'SHEA, E. et al. 1998. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37: 919-926.
17. MORLEY, K.C. & I.S. MCGREGOR. 2000. (±)-3,4- methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Eur. J. Pharmacol. 408: 41-49.
18. MECHAN, A.O. et al. 2002. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology (Berl.) 159: 167-175.
19. INSEL, T.R. 1995. The development of brain and behavior. In Psychopharmacology: the Fourth Generation of Progress. D.J. Kupfer, Ed.: 683-694. Raven Press. New York.
20. GREBA, Q., A. GIFKINS & L. KOKKINIDIS. 2001. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 899: 218-226.
21. ANTONIADIS, E.A. & R.J. MCDONALD. 2001. Amygdala, hippocampus, and unconditioned fear. Exp. Brain Res. 138: 200-209.
22. O'LOINSIGH, E.D. et al. 2001. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 25: 621-638.
23. GREEN, A.R., E. O'SHEA & M.I. COLADO. 2004. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur. J. Pharmacol. 500: 3-13.